Advertisement

Health


OncoSil Medical files for FDA approval of bile duct cancer device in major US milestone

OncoSil Medical files for FDA approval of bile duct cancer device in major US milestone

Sydney-based medical device company OncoSil Medical (ASX: OSL) has ...

BellaSeno ramps up human trials of regenerative breast scaffolds after Johnson & Johnson partnerhsip

BellaSeno ramps up human trials of regenerative breast scaffolds after Johnson & Johnson partnerhsip

Clinical-stage medtech BellaSeno, a company founded in Australia an...

Biome Australia shares surge 17pc as probiotics firm tracks toward record full-year revenue

Biome Australia shares surge 17pc as probiotics firm tracks toward record full-year revenue

Shares in probiotics company Biome Australia (ASX: BIO) surged&nbsp...

Echo IQ raises $110 million to fuel US expansion and cardiovascular AI pipeline

Echo IQ raises $110 million to fuel US expansion and cardiovascular AI pipeline

Sydney-based medtech Echo IQ Limited (ASX: EIQ) has secured firm co...

Medtech startup Oli backs up $6.5m raise with $2m federal grant to build Sydney manufacturing base

Medtech startup Oli backs up $6.5m raise with $2m federal grant to build Sydney manufacturing base

Sydney-based maternal health technology company Oli has secured $2 ...

Advertisement
Advertisement
Advertisement
Women’s health platform Ovum triples valuation to $18m in a year after $4m seed round

Women’s health platform Ovum triples valuation to $18m in a year after $4m seed round

Australian women’s health startup Ovum has backed up a $1.7 m...

Clinical-stage biotech Racura Oncology raises $34.3m to fully fund three cancer drug trials

Clinical-stage biotech Racura Oncology raises $34.3m to fully fund three cancer drug trials

Clinical-stage biotechnology company Racura Oncology (ASX: RAC) has...

Biotech Memphasys secures supply deal with Monash IVF for Felix sperm selection system

Biotech Memphasys secures supply deal with Monash IVF for Felix sperm selection system

Sydney-based reproductive biotech Memphasys (ASX: MEM) has secured ...

Takeover target Monash IVF slashes full-year profit guidance as cycle volumes decline

Takeover target Monash IVF slashes full-year profit guidance as cycle volumes decline

Almost two months after rejecting a $350 million takeover bid ...

Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility

Melbourne-based probiotics company Biome Australia (ASX: BIO) has s...

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

AI-powered biotech startup Gutgutgoose accepted into Silicon Valley's Y Combinator

Queensland-based biotech startup Gutgutgoose has been accepted into...

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

4DMedical locks in US radiology deal, European acquisition and clinical program in five-day blitz

Melbourne-based respiratory imaging company 4DMedical (ASX: 4DX) ha...

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo strikes WA Government-backed deal for Healthscope's Mount Private Hospital in Perth

HealthCo Healthcare & Wellness REIT (ASX: HCW) has secured a ne...

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

ANDHealth awards $9m to five digital health startups as sector sounds alarm on capital access

Digital health accelerator ANDHealth has awarded up to $9 million i...

Mayne Pharma wins $13.27m costs award against Cosette from collapsed $672m takeover battle

Mayne Pharma wins $13.27m costs award against Cosette from collapsed $672m takeover battle

Adelaide-based pharmaceutical manufacturer Mayne Pharma (ASX: MYX) ...

Healius shares slump 23pc as rising costs hit pathology giant with no relief from federal budget

Healius shares slump 23pc as rising costs hit pathology giant with no relief from federal budget

Pathology operator Healius (ASX: HLS) has downgraded its full-year ...

CSL shares bleed to decade low after $6.9 billion writedown as turnaround timeline blows out

CSL shares bleed to decade low after $6.9 billion writedown as turnaround timeline blows out

Shares in Australian blood products giant CSL Limited (ASX: CSL) ha...

Cochlear-backed Epiminder ramps up US epilepsy study as cash runway stretches into 2028

Cochlear-backed Epiminder ramps up US epilepsy study as cash runway stretches into 2028

Melbourne-based medical device company Epiminder (ASX: EPI) has rep...

Syntara raising $10m to advance myelofibrosis drug toward Phase 2b trial

Syntara raising $10m to advance myelofibrosis drug toward Phase 2b trial

Clinical-stage biotech Syntara Limited (ASX: SNT) has secured firm ...

Emyria locks in fifth psychedelic therapy clinic as national rollout hits all major states

Emyria locks in fifth psychedelic therapy clinic as national rollout hits all major states

Perth-headquartered mental health treatment company Emyria Limited ...

Advertisement

Partner Content

Australian businesses are operating in one of the most difficult tr...
Critical infrastructure underpins the functioning of modern societi...
Join a global community of leaders navigating increasingly complex ...
A profound shift is underway in how people shop online with retaile...
Equi Consultancy Partners joined regional leaders at the WEConnect ...
If you run a business website, it’s easy to focus on what custome...
The growth of e-commerce has been driven by small, lightweight prod...
Advertisement